 |
인쇄하기
취소
|
KFDA approves two homegrown drugs
Published: 2011-08-22 06:58:00
Updated: 2011-08-22 06:58:00
Demonstrating the strength of the country's R&D capabilities, the Korea Food and Drug Administration Wednesday approved two Korean drugs – Shinpoong Pharmaceutical’s anti-malarial drug ‘Pyramax’ and JW Pharmaceutical’s Zepid (avanafil) for treatment of erectile dysfunction (ED).
Thus Korea becomes a country to develop 17 new drugs and the two products may generate significant sales unlike ot...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.